Health In Tech, Inc. (HIT) 주식 분석
기술Health In Tech, Inc.
$0.87
$-0.03 (-3.62%)
최종 업데이트: 2026년 5월 26일
가격 추이
가격 데이터가 없습니다
분석
회사 개요
Health In Tech, Inc. is a specialized insurance technology platform that provides reference-based pricing, group insurance captives, community health plans, and association health programs tailored for small businesses. The company also utilizes an enhance do it yourself benefit system (eDIYBS), which functions as a web-based SaaS quoting solution to streamline benefit administration. Operating within the Technology sector, specifically in the Software - Application industry, the firm focuses on delivering digital infrastructure for the healthcare and insurance sectors. With a market capitalization of $91.78M and annual revenue of $33.33M, the company holds a mid-cap position that suggests it is a significant but not dominant player in its niche market. The employee count is currently listed as N/A, indicating that precise staffing scale data is not publicly disclosed in the available reports. These financial metrics collectively illustrate an enterprise that has achieved a substantial market valuation relative to its revenue base, reflecting high growth expectations or significant asset-light operational models common in software applications. The disparity between its substantial market cap and relatively modest revenue highlights the market's premium on its proprietary technology and platform capabilities rather than current profit generation alone.
재무 건전성
Health In Tech, Inc. reported a trailing twelve-month revenue of $33.33M, with a corresponding net income of $1.28M and an EBITDA of $2.43M. The gap between the $33.33M revenue and the $1.28M net income reveals a cost structure where non-operating expenses or specific tax liabilities significantly impact the bottom line, despite a healthy gross margin. The company generated negative free cash flow of -$2,304,041, which indicates a heavy capital expenditure requirement or timing mismatch between cash inflows and outflows, potentially limiting immediate financial flexibility for large-scale acquisitions. However, the firm maintains a robust cash position of $7.67M against a negligible debt level of $139,812, providing a substantial liquidity buffer to cover short-term obligations. The gross margin stands at 62.8%, demonstrating high pricing power and efficient delivery costs typical of software products, while the operating margin of -2.3% suggests that current operational expenses are temporarily outpacing revenue growth. Conversely, the profit margin of 3.8% indicates that the company remains profitable on a net basis despite the negative operating margin, likely due to non-operating income or specific accounting adjustments. The debt-to-equity ratio of 0.82 combined with the low absolute debt figure portrays a balance sheet that is conservative regarding leverage but carries some financial obligation. Furthermore, the current ratio of 3.13 signals strong short-term liquidity, as the company holds sufficient current assets to cover its current liabilities more than three times over. Return on Equity is recorded at 8.4% and Return on Assets at 4.9%, metrics that reveal management's effectiveness in generating returns on shareholders' capital and the total asset base, respectively, relative to the company's valuation.
밸류에이션 평가
The trailing twelve-month P/E ratio is 70.00, while the forward P/E ratio is significantly lower at 7.57. This stark difference between the two metrics implies that the market expects a dramatic improvement in earnings per share in the coming year, potentially driven by one-time gains or a rapid normalization of operating costs. The price-to-book ratio of 4.71 indicates that the market values the company at a substantial premium over its net asset value, reflecting confidence in its intangible assets like intellectual property and software platforms. Additionally, the price-to-sales ratio of 2.75 and the EV/EBITDA of 31.46 provide alternative valuation perspectives that suggest the stock is priced based on growth potential rather than current earnings power. The 52-week high is $4.02 and the 52-week low is $0.51, creating a trading range of $3.51. Without the specific current share price provided in the facts, the exact percentage position relative to this range cannot be calculated, but the wide range suggests high volatility and significant recent price appreciation from the low end. The beta value is listed as N/A, meaning volatility relative to the broader market cannot be quantified with the available data. These valuation metrics collectively present a picture of a high-growth technology stock that commands a premium valuation multiple despite currently low absolute earnings.
Growth & Income
Revenue growth year-over-year is 53.1%, while earnings growth year-over-year is N/A due to the lack of historical earnings data in the provided metrics. The absence of a comparable prior year earnings figure makes it impossible to determine if earnings are growing faster or slower than revenue, but the massive revenue expansion indicates a rapidly scaling business model. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%. This non-dividend status implies that the company retains all of its earnings to reinvest into technology development, market expansion, and operational scaling rather than distributing cash to shareholders. Consequently, the overall growth and income profile is defined by aggressive revenue expansion and a strategy of capital retention to fuel future growth rather than providing current income to investors.
동종업체 비교
Health In Tech, Inc. (HIT) 은(는) 소프트웨어 - 애플리케이션 산업에서 운영됩니다. 시가총액 기준으로 가장 가까운 동종업체와의 비교는 다음과 같습니다:
| 기업명 | 티커 | 시가총액 | PER |
|---|---|---|---|
| Health In Tech, Inc. | HIT | $56.79M | N/A |
| SAP SE | SAP | $206.49B | 24.1 |
| Shopify Inc. | SHOP.TO | $188.02B | 102.8 |
| Salesforce, Inc. | CRM | $146.50B | 22.9 |
소프트웨어 - 애플리케이션 산업 평균 PER은 45.6배입니다. Health In Tech, Inc.의 PER은 N/A입니다.
이 분석은 AI가 생성한 것으로 정보 제공 목적으로만 사용되며 투자 조언이 아닙니다. 데이터가 지연되거나 부정확할 수 있습니다. 투자 결정을 내리기 전에 항상 직접 조사하고 자격을 갖춘 재무 상담사와 상담하세요.
관련 소프트웨어 - 애플리케이션 종목
SAP SE
$206.49B
SHOP.TOShopify Inc.
$188.02B
CRMSalesforce, Inc.
$146.50B
UBERUber Technologies, Inc.
$142.74B
SHOPShopify Inc.
$136.12B
NOWServiceNow, Inc.
$105.33B
기술 인기 주식
NVIDIA Corporation
$6.77T
AAPL.TOApple Inc.
$5.97T
NVDANVIDIA Corporation
$5.22T
AAPLApple Inc.
$4.53T
MSFT.TOMicrosoft Corporation
$4.10T
Health In Tech, Inc. 소개
Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which specializes in underwriting and providing administrative functions on behalf of stop loss carriers; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers. It also provides health intelligence (HI) cards to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.
회사 설명은 영어로 표시됩니다.
웹사이트 방문 →주요 지표
- 시가총액
- $56.79M
- PER
- N/A
- 52주 최고가
- $4.02
- 52주 최저가
- $0.56
- 평균 거래량
- 382.53K
데이터는 yfinance를 통해 Yahoo Finance에서 제공됩니다. 매일 업데이트.
기업 정보
- 거래소
- NASDAQ
- 국가
- United States
- 직원 수
- 87